CCL5 and neoplasm: Another study demonstrated that an 8-hydroxyquinoline derivative effectively suppresses esophageal tumor invasion by downregulating CCL5 expression, suggesting that CCL5 may serve as a potential therapeutic target for inhibiting tumor progression (Tang et al., 2024).